The Potential of Medical Abortion to Reduce Maternal Mortality in Africa: What Benefits for Tanzania and Ethiopia?

作者: Rebecca F. Baggaley , Joanna Burgin , Oona M. R. Campbell

DOI: 10.1371/JOURNAL.PONE.0013260

关键词: Medical abortionFamily planningAbortionObstetricsPopulationTanzaniaBirth rateEnvironmental healthMedicineChildbirthUnsafe abortionGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: BACKGROUND: Unsafe abortion is estimated to account for 13% of maternal mortality globally. Medical a safe alternative. METHODS: By estimating risks unsafe and medical childbirth Tanzania Ethiopia, we modelled changes in that are achievable if were replaced by abortion. We selected Ethiopia because their high ratios (MMRatios) contrasting situations regarding health care provision legislation. focused on misoprostol-only regimens due the drug's low cost accessibility. included impact women who would otherwise choose with unwanted/mistimed pregnancies carry term. RESULTS: Thousands lives could be saved each year country implementing using misoprostol (2122 2551 assuming coverage equals family planning services levels: 56% Tanzania, 31% Ethiopia). Changes MMRatios less pronounced intervention also affect national birth rates. CONCLUSIONS: This first analysis which takes into additional potential users other than those currently women's saved, but this may not reflected as substantial abortion's demographic impact. Therefore policy makers must aware inability some traditional measures detect real benefits offered such an intervention.

参考文章(51)
Ethiopia, Central Statistical Agency Csa, Ethiopia demographic and health survey, 2000 The Authority , ORC Macro. ,(2001)
D Hu, D Grossman, C Levin, K Blanchard, SJ Goldie, Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City. British Journal of Obstetrics and Gynaecology. ,vol. 116, pp. 768- 779 ,(2009) , 10.1111/J.1471-0528.2009.02142.X
Haitham Hamoda, Premila W. Ashok, Gillian M.M. Flett, Allan Templeton, Medical abortion at 9–13 weeks' gestation: a review of 1076 consecutive cases Contraception. ,vol. 71, pp. 327- 332 ,(2005) , 10.1016/J.CONTRACEPTION.2004.10.015
Daniel Grossman, Kelly Blanchard, Paul Blumenthal, Complications after Second Trimester Surgical and Medical Abortion Reproductive Health Matters. ,vol. 16, pp. 173- 182 ,(2008) , 10.1016/S0968-8080(08)31379-2
Deborah L Billings, Misoprostol Alone for Early Medical Abortion in a Latin American Clinic Setting Reproductive Health Matters. ,vol. 12, pp. 57- 64 ,(2004) , 10.1016/S0968-8080(04)24010-1
Ann Lovold, Cynthia Stanton, Deborah Armbruster, How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention International Journal of Gynecology & Obstetrics. ,vol. 103, pp. 276- 282 ,(2008) , 10.1016/J.IJGO.2008.08.009
C.C. Harper, K. Blanchard, D. Grossman, J.T. Henderson, P.D. Darney, Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings International Journal of Gynecology & Obstetrics. ,vol. 98, pp. 66- 69 ,(2007) , 10.1016/J.IJGO.2007.03.009
S.H Costa, M.P Vessey, Misoprostol and illegal abortion in Rio de Janeiro, Brazil. The Lancet. ,vol. 341, pp. 1258- 1261 ,(1993) , 10.1016/0140-6736(93)91156-G
Maria M. Fernandez, Francine Coeytaux, Rodolfo Gomez Ponce de León, Denise L. Harrison, Assessing the global availability of misoprostol. International Journal of Gynecology & Obstetrics. ,vol. 105, pp. 180- 186 ,(2009) , 10.1016/J.IJGO.2008.12.016